BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 11238734)

  • 1. Signaling pathways in the induction of c-met receptor expression by its ligand scatter factor/hepatocyte growth factor in human glioblastoma.
    Abounader R; Ranganathan S; Kim BY; Nichols C; Laterra J
    J Neurochem; 2001 Mar; 76(5):1497-508. PubMed ID: 11238734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase- and AKT-dependent pathways.
    Bowers DC; Fan S; Walter KA; Abounader R; Williams JA; Rosen EM; Laterra J
    Cancer Res; 2000 Aug; 60(15):4277-83. PubMed ID: 10945642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression.
    Abounader R; Ranganathan S; Lal B; Fielding K; Book A; Dietz H; Burger P; Laterra J
    J Natl Cancer Inst; 1999 Sep; 91(18):1548-56. PubMed ID: 10491431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
    Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative control of the HGF/c-MET pathway by TGF-β: a new look at the regulation of stemness in glioblastoma.
    Papa E; Weller M; Weiss T; Ventura E; Burghardt I; Szabó E
    Cell Death Dis; 2017 Dec; 8(12):3210. PubMed ID: 29238047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth.
    Cai W; Rook SL; Jiang ZY; Takahara N; Aiello LP
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1885-93. PubMed ID: 10845613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A natural hepatocyte growth factor/scatter factor autocrine loop in myoblast cells and the effect of the constitutive Met kinase activation on myogenic differentiation.
    Anastasi S; Giordano S; Sthandier O; Gambarotta G; Maione R; Comoglio P; Amati P
    J Cell Biol; 1997 Jun; 137(5):1057-68. PubMed ID: 9166406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation mechanisms of the urokinase-type plasminogen activator promoter by hepatocyte growth factor/scatter factor.
    Ried S; Jäger C; Jeffers M; Vande Woude GF; Graeff H; Schmitt M; Lengyel E
    J Biol Chem; 1999 Jun; 274(23):16377-86. PubMed ID: 10347197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways.
    Xiao GH; Jeffers M; Bellacosa A; Mitsuuchi Y; Vande Woude GF; Testa JR
    Proc Natl Acad Sci U S A; 2001 Jan; 98(1):247-52. PubMed ID: 11134526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional activation of the hepatocyte growth factor receptor (c-met) gene by its ligand (hepatocyte growth factor) is mediated through AP-1.
    Seol DW; Chen Q; Zarnegar R
    Oncogene; 2000 Feb; 19(9):1132-7. PubMed ID: 10713700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1.
    Recio JA; Merlino G
    Oncogene; 2002 Feb; 21(7):1000-8. PubMed ID: 11850817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of matrix metalloproteinase-2 (MMP-2) by hepatocyte growth factor/scatter factor (HGF/SF) in human glioma cells: HGF/SF enhances MMP-2 expression and activation accompanying up-regulation of membrane type-1 MMP.
    Hamasuna R; Kataoka H; Moriyama T; Itoh H; Seiki M; Koono M
    Int J Cancer; 1999 Jul; 82(2):274-81. PubMed ID: 10389763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitogenic synergy through multilevel convergence of hepatocyte growth factor and interleukin-4 signaling pathways.
    Day RM; Soon L; Breckenridge D; Bridges B; Patel BK; Wang LM; Corey SJ; Bottaro DP
    Oncogene; 2002 Mar; 21(14):2201-11. PubMed ID: 11948403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PKC, p42/44 MAPK and p38 MAPK regulate hepatocyte growth factor secretion from human astrocytoma cells.
    Chattopadhyay N; Tfelt-Hansen J; Brown EM
    Brain Res Mol Brain Res; 2002 Jun; 102(1-2):73-82. PubMed ID: 12191496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte growth factor signal coupling to various transcription factors depends on triggering of Met receptor and protein kinase transducers in human hepatoma cells HepG2.
    Tacchini L; Dansi P; Matteucci E; Desiderio MA
    Exp Cell Res; 2000 Apr; 256(1):272-81. PubMed ID: 10739674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotection by scatter factor/hepatocyte growth factor and FGF-1 in cerebellar granule neurons is phosphatidylinositol 3-kinase/akt-dependent and MAPK/CREB-independent.
    Hossain MA; Russell JC; Gomez R; Laterra J
    J Neurochem; 2002 Apr; 81(2):365-78. PubMed ID: 12064484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1.
    Recio JA; Merlino G
    Cancer Res; 2003 Apr; 63(7):1576-82. PubMed ID: 12670907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma.
    Price JA; Kovach SJ; Johnson T; Koniaris LG; Cahill PA; Sitzmann JV; McKillop IH
    Hepatology; 2002 Nov; 36(5):1089-97. PubMed ID: 12395318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective activation of phospholipase C gamma1 and distinct protein kinase C subspecies in intracellular signaling by hepatocyte growth factor/scatter factor in primary cultured rat neocortical cells.
    Machide M; Kamitori K; Nakamura Y; Kohsaka S
    J Neurochem; 1998 Aug; 71(2):592-602. PubMed ID: 9681449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in hepatocyte growth factor receptor tyrosine kinase activity in renal carcinoma cells is associated with increased motility partly through phosphoinositide 3-kinase activation.
    Nakamura T; Kanda S; Yamamoto K; Kohno T; Maeda K; Matsuyama T; Kanetake H
    Oncogene; 2001 Nov; 20(52):7610-23. PubMed ID: 11753639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.